Aclaris Therapeutics Shares Slide to Two-Year Lows on Study Failure >ACRS
The Wayne, Pa., company, which is also studying zunsemetinib in rheumatoid arthritis and psoriatic arthritis, said the drug was generally well ... The Wayne, Pa., company, which is also studying…